Filing Details

Accession Number:
0000950170-24-005513
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-18 18:18:45
Reporting Period:
2024-01-16
Accepted Time:
2024-01-18 18:18:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1880438 An2 Therapeutics Inc. ANTX () E9
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1783165 Adjuvant Global Health Technology Fund, L.p. C/O Adjuvant Capital, L.p.
501 Fifth Avenue, Suite 1404
New York NY 10017
No No No No
1799812 Adjuvant Global Health Technology Fund De, L.p. C/O Adjuvant Capital, L.p.
501 Fifth Avenue, Suite 1404
New York NY 10017
No No No No
1935084 Adjuvant Capital Management, Llc C/O Adjuvant Capital, L.p.
501 Fifth Avenue, Suite 1404
New York NY 10017
No No No No
1935100 Adjuvant Capital Gp, L.p. C/O Adjuvant Capital, L.p.
501 Fifth Avenue, Suite 1404
New York NY 10017
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-16 84,093 $19.65 1,995,958 No 4 S Direct
Common Stock Disposition 2024-01-16 15,907 $19.65 377,542 No 4 S Indirect By Adjuvant Global Health Technology Fund DE, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By Adjuvant Global Health Technology Fund DE, L.P.
Footnotes
  1. Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
  2. Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.